宝莱特收盘下跌1.35%，最新市净率1.64，总市值19.34亿元

Group 1 - The core business of Baolait Medical Technology Co., Ltd. includes research, production, sales, and service of medical device products, with key products such as monitoring devices, ECG machines, infusion pumps, pulse oximeters, central monitoring systems, and wearable medical products [1] - As of the first quarter of 2025, Baolait reported a revenue of 248 million yuan, a year-on-year decrease of 7.17%, and a net profit of 14.45 million yuan, a year-on-year increase of 298.35%, with a gross profit margin of 27.39% [1] - The company holds a total of 70 authorized invention patents, 278 utility model patents, 49 design patents, 3 international patents, 115 software copyrights, and 122 trademarks, along with 87 medical device registration certificates [1] Group 2 - Baolait's current price-to-earnings (P/E) ratio (TTM) is -31.90, with a price-to-book (P/B) ratio of 1.64 and a total market capitalization of 1.934 billion yuan [2] - The industry average P/E ratio is 48.81, while the industry median P/E ratio is 35.46, indicating that Baolait's valuation metrics are significantly lower than the industry averages [2]